Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Sep 11;58(9):1257.
doi: 10.3390/medicina58091257.

Antibiotic Abuse and Antimicrobial Resistance in Hospital Environment: A Retrospective Observational Comparative Study

Affiliations
Observational Study

Antibiotic Abuse and Antimicrobial Resistance in Hospital Environment: A Retrospective Observational Comparative Study

Patrizia Nardulli et al. Medicina (Kaunas). .

Abstract

Background and Objectives: Antimicrobial resistance represents a serious problem, and it may be life-threatening in the case of severe hospital-acquired infections (HAI). Antibiotic abuse and multidrug resistance (MDR) have significantly increased this burden in the last decades. The aim of this study was to investigate the distribution and susceptibility rates of five selected bacterial species (E. coli, K. pneumoniae, P. aeruginosa, S. aureus and E. faecium) in two healthcare settings located in the Apulia region (Italy). Materials and Methods: Setting n.1 was a university hospital and setting n.2 was a research institute working on oncological patients. All the enrolled patients were diagnosed for bacterial HAI. The observation period was between August and September 2021. Clinical samples were obtained from several biological sources, in different hospital wards. Bacterial identification and susceptibility were tested by using the software VITEC 2 Single system. Results: In this study, a higher incidence of multi-drug-resistant K. pneumoniae was reported (42,2% in setting n.1 and 50% in setting n.2), with respect to the Italian 2019 statistics report (30.3%). All the isolates of E. faecium and S. aureus were susceptible to linezolid. All the bacterial isolates of P. aeruginosa and most of K. pneumoniae were susceptible to ceftazidime-avibactam. Amikacin and nitrofurantoin represented a good option for treating E. coli infections. Multidrug-resistant (MDR) P. aeruginosa, methicillin-resistant S. aureus (MRSA) and vancomycin-resistantE. faecium (VRE) had a lower incidence in the clinical setting, with respect to E. coli and K. pneumoniae. Conclusions: The data obtained in this study can support clinicians towards a rational and safe use of antibiotics for treating the infections caused by these resistant strains, to enhance the overall efficacy of the current antibiotic protocols used in the main healthcare environments.

Keywords: antibiotics; antimicrobial resistance; bacterial isolates; clinical setting; infections; multidrug resistance.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Aly N.Y.A., Al-Mousa H.H., El Sayed M. Nosocomial infections in a medical-surgical intensive care unit. Med. Princ. and Pract. 2008;17:373–377. doi: 10.1159/000141500. - DOI - PubMed
    1. Fusco A., Dicuonzo G., Dell’Atti V., Tatullo M. Blockchain in Healthcare: Insights on COVID-19. Int. J. Environ. Res. Public Health. 2020;17:7167. doi: 10.3390/ijerph17197167. - DOI - PMC - PubMed
    1. Condò R., Mampieri G., Pasquantonio G., Giancotti A., Pirelli P., Cataldi M.E., La Rocca S., Leggeri A., Notargiacomo A., Maiolo L., et al. In vitro evaluation of structural factors favouring bacterial adhesion on orthodontic adhesive resins. Materials. 2021;14:2485. doi: 10.3390/ma14102485. - DOI - PMC - PubMed
    1. Legras A., Malvy D., Quinioux A.I., Villers D., Bouachour G., Robert R., Thomas R. Nosocomial infections: Prospective survey of incidence in five French intensive care units. Intensive Care Med. 1998;24:1040–1046. doi: 10.1007/s001340050713. - DOI - PubMed
    1. Kumar M., Sarma D.K., Shubham S., Kumawat M., Verma V., Nina P.B., Devraj J.P., Kumar S., Singh B., Tiwari R.R. Futuristic non-antibiotic therapies to combat antibiotic resistance: A review. Front. Microbiol. 2021;12:609459. doi: 10.3389/fmicb.2021.609459. - DOI - PMC - PubMed

Publication types